Abstract
Cardiovascular disease as cardiac infarction is referred to as one of the three major adult diseases, and the number of the patients is increased with each passing year. Now the method of stent placement, which is numerously used for treatment of the ischemia disease, was put to practical use about twenty years ago, alleviated physical and economic strains, and was uplifting quality of life. However, the market of Japan shows an excess of imports as in the case of other medical devices, and the manufacturing technology of small and medium-sized enterprises in Japan are not working well. Since its establishment in 2003, our company has been developing and commercializing the stents made in Japan, and reported below.
